The Inception Research Institute (IRI) and The Prelude Network®, both part of the Inception Fertility™ ecosystem, in collaboration with Cooper Surgical and Igenomix (part of Vitrolife Group), have launched an innovative research initiative to study the outcomes of non-euploid embryos.
The Non-Euploid Embryo Transfer (NEET) Registry is the most comprehensive prospective study of its kind, designed to track not only pregnancy outcomes but also the pediatric development and health of children born from non-euploid embryos. Developmental assessments will be conducted at two months, six months, one year, two years, and five years of age.
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is widely offered as an option for patients pursuing pregnancy through in vitro fertilization (IVF). Most often, embryos with normal chromosome results are selected for transfer, with well-established outcomes. Transferring an embryo with a non-euploid result (i.e., mosaic, isolated segmental aneuploid or aneuploidy of whole chromosome(s)) may be considered for a variety of patient specific reasons. However, little information is available on the long-term outcomes of mosaic embryo transfer. Even less has been published on outcomes for other types of non-euploid results.
The NEET Registry aims to collect prenatal, neonatal and pediatric outcome information for embryos transferred with the various types of non-euploid PGT-A results to support providers and patients in their decision making regarding such transfers.
“This study will give fertility providers more data on the outcomes of non-euploid embryos beyond pregnancy success rates so they can empower their patients with the information needed to build their families,” says Lauri Black, MS, CGC, Vice President of Genetic Services at Inception Fertility. “This research has the potential to reshape how we counsel patients, giving them greater clarity and confidence as they make deeply personal decisions about their family-building journeys.”
The Inception Research Institute is dedicated to advancing all aspects of fertility care through groundbreaking research and strategic partnerships. The Prelude Network is Inception Fertility’s clinical network of top-tier fertility practices across North America.
To learn more about the Inception Research Institute, please visit inceptionfertility.com/inception-research-institute. To learn more about the NEET Registry, please visit fertilitystudies.com/neet/.
About Inception Research Institute (IRI)
Established in 2022, the Inception Research Institute, part of Inception Fertility™, advances the field of reproductive medicine by addressing the industry’s most urgent needs — including pharmacological innovation, device development, professional advancement, access to care, and studies exploring how controllable factors such as emotional health and lifestyle habits affect treatment outcomes.
The Institute supports research across The Prelude Network® — Inception’s national network of top-tier fertility clinics — by centralizing services such as IRB applications, contract review, and patient recruitment. Research conducted through the Institute has been published in leading peer-reviewed journals and presented at global forums such as ASRM and ESHRE, including a landmark 15-year study on egg freezing.
With the largest number of current studies in North America focusing on improving the patient experience, enhancing patient-centered care, researching the relationship between stress and treatment outcome, and investigating the most effective stress-reduction strategies, the Inception Fertility Research Institute continues to be an industry leader.
To learn about active studies led by the Inception Research Institute, visit fertiltystudies.com.
Media Contact
Mia Humphreys
mhumphreys@kruppagency.com
+1 239-297-6592
